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ABSTRACT 
 
BACKGROUND: 
 Patients with periodontal disease have differences in the protein 
composition of whole saliva, which reflects the nature and amplitude of 
the host response to a periodontal  microbial challenge.  
 
 Amylase and Mucin displays  inhibitory activity against micro-
organisms and enhances the protective potential  of saliva.  
 
 To know whether laboratory estimation of amylase and mucin 
can be used as a reliable biochemical marker to evaluate the 
progression of periodontal disease.  
 
AIM: 
 The  aim  of this study is  to compare the quantitative levels of 
salivary amylase  and  mucin  before  and  after  scaling  and root 
planing in patients with  chronic  generalised periodontitis patients.  
 
MATERIALS & METHODS: 
 A total number  of  40 subjects (20 with Periodontally healthy 
volunteers and 20 with Chronic generalised periodontitis  of  25-65  yrs 
were included in the study. After getting the informed consent signed, 
all the individuals  participated  in  the study  were subjected to 
measurement of clinical parameters such as OHI-S, Gingival index, 
Probing depth, CAL and then  saliva sample  collection  was  do ne  and 
analysed for Amylase,  Mucin levels by Semi auto analyser, 
Spectrophotometer respectively.  The clinical parameters,  salivary  
amylase  and mucin levels were re -evaluated  after  45 days  following  
phase I  periodontal  therapy.  
  
 The results were statistically analysed using Independent  
samples t -test,  Paired samples t-test , and Karl Pearson`s correlation 
analysis.  
 
RESULTS: 
 At baseline,  salivary amylase and mucin leve ls were  
significantly high  in patients with  Chronic generalised periodontitis 
with increase in clinical parameters  such  as OHI-S, Gingival index,  
Probing depth, CAL when compared with periodontally healthy 
individuals.  The salivary amylase and mucin   levels were  significantly 
reduced following phase I periodontal  therapy  along with improvement 
in clinical parameters, thus exhibiting a positive  correlation between 
clinical parameters  with both salivary amylase and mucin levels and 
also there was positive correlation between salivary amylase  and  
mucin  levels  pre-operatively as well as post -operatively.  P values 
from statistical tests presented were found to be stati stically  
significant at  P-value < 0.001.  
 
CONCLUSION: 
 Within the l imitations of  the present study, It could be concluded  
that  amylase  and mucin levels in saliva can be used for the diagnosis 
of active phase of periodontal disease and to detect treatment outcom es 
following periodontal phase I  therapy.  
 
 
 
 
 
 
 
